DANBURY, Conn. , July 10, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that management will be presenting an overview of the Company's technologies, development programs, and outlook on Friday, July 13, 2012 at 11:30 a.m. EDT at the Seventh Annual JMP Securities Healthcare Conference ( New York, July 12 - 13). A live and archived webcast of the presentation will be accessible by visiting the Biodel website at www.biodel.com under "Webcasts" in the "News & Events" section. About Biodel Inc. Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. BIOD-G Contact: Seth D. Lewis, +1-646-378-2952 News Provided by Acquire Media SOURCE Biodel Inc.